C12N 2310/00
Structure or type of the nucleic acid
C12N2310/00 (Structure or type of the nucleic acid) appears on 15,328 US grants and 31,436 published applications in this corpus.
Search patents in C12N- Granted patents
- 15,328
- Published applications
- 31,436
- Assignees
- 5,864
- Inventors
- 39,508
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 5 | 0 |
| 1992 | 11 | 0 |
| 1993 | 22 | 0 |
| 1994 | 12 | 0 |
| 1995 | 29 | 0 |
| 1996 | 58 | 0 |
| 1997 | 154 | 0 |
| 1998 | 184 | 0 |
| 1999 | 202 | 0 |
| 2000 | 228 | 0 |
| 2001 | 189 | 29 |
| 2002 | 183 | 163 |
| 2003 | 115 | 534 |
| 2004 | 103 | 573 |
| 2005 | 69 | 558 |
| 2006 | 93 | 470 |
| 2007 | 93 | 545 |
| 2008 | 107 | 502 |
| 2009 | 204 | 810 |
| 2010 | 343 | 877 |
| 2011 | 388 | 894 |
| 2012 | 488 | 894 |
| 2013 | 516 | 880 |
| 2014 | 591 | 967 |
| 2015 | 705 | 1295 |
| 2016 | 702 | 1404 |
| 2017 | 791 | 1308 |
| 2018 | 871 | 1578 |
| 2019 | 977 | 1767 |
| 2020 | 969 | 1889 |
| 2021 | 1031 | 2121 |
| 2022 | 1019 | 2279 |
| 2023 | 968 | 2332 |
| 2024 | 994 | 2530 |
| 2025 | 1066 | 2456 |
| 2026 | 844 | 1781 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for optimized RIG-I ligands6 Oct 2026US 12,751,965 B2
- ß-amyloid cyclic ribonucleic acid, polypeptide, and application thereof6 Oct 2026US 12,753,215 B2
- Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis6 Oct 2026US 12,753,384 B2Cornell Research Foundation, Inc.
- Prime editor system for in vivo genome editing6 Oct 2026US 12,753,397 B2University of Massachusetts
- CRISPR-mediated directed codon re-write6 Oct 2026US 12,753,398 B2Limagrain Europe S.A.
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Methods and compositions for microbial delivery of double stranded rna8 Oct 2026US 2026/0305618 A1Rnaissance AG LLC
- Composition and Method for Topical Trans-spinal Delivery of Nucleic Acids and Small Molecules8 Oct 2026US 2026/0306414 A13P Biotechnologies, Inc.
- Methods of preventing on-target genotoxicity induced by nucleases8 Oct 2026US 2026/0306552 A1Chu De Bordeaux
- Modular platform for molecular conjugation8 Oct 2026US 2026/0306645 A1CamBrixBio Ltd
Most cited
By later US patents
- CRISPR-Cas systems and methods for altering expression of gene products1,186US 8,697,359 B1Massachusetts Institute of Technology · 2014
- Genetic inhibition by double-stranded RNA1,185US 6,506,559 B1Carnegie Institute of Washington · 2003
- Transgenic non-human animals capable of producing heterologous antibodies950US 5,770,429 AGenPharm International, Inc. · 1998
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Antisense oligonucleotide modulation of multidrug resistance-associated protein841US 5,801,154 AIsis Pharmaceuticals, Inc. · 1998